Drug Database
Back to search

Japan· JP-2619702Q6045

クロルヘキシジングルコン酸塩

A chlorhexidine product containing クロルヘキシジングルコン酸塩, registered in Japan by 日興製薬, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.

On Japan’s NHI price listATC B05CA02

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedクロルヘキシジングルコン酸塩ATCB05CA02REGISTER NO.JP-2619702Q6045PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about クロルヘキシジングルコン酸塩Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Chlorhexidine is registered in 3 of 19 countries.

Countries holding a registration under ATC B05CA02 (chlorhexidine), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
Search chlorhexidine products by name

Chlorhexidine · ATC B05CA02

3 / 19 countries

  • Ireland
  • Japan
  • Netherlands
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
クロルヘキシジングルコン酸塩
Manufacturer
日興製薬
Country
Japan (JP)
ATC code
B05CA02
ATC class
Chlorhexidine
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

183 interactions on record for chlorhexidine.

Graded by severity as the source publishes them — 183 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check chlorhexidine against other medicinesHow interaction checks work

Chlorhexidine · interactions on record

183 records

  • 183 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same class

    Other records under B05CA02

    Chlorhexidine, as other registers publish it.

    All chlorhexidine products

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/de28c422-a89a-4c55-848d-13d934827c10
GET /v1/drugs/de28c422-a89a-4c55-848d-13d934827c10?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "spec": "０．０５％１０ｍＬ",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2619702Q6045",
  "category": "外用薬",
  "price_yen": 7,
  "generic_name": "クロルヘキシジングルコン酸塩",
  "product_name_jp": null,
  "therapeutic_class": "2619",
  "transitional_expiry": null
}
    API referenceMCP serverPlans

    See everything about chlorhexidine.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console